Hyderabad, 19th February, 2026: Zeus Hygia Lifesciences, a science-led nutraceutical ingredient innovator, today announced the signing of a Memorandum of Understanding (MOU) with UK-based Patch House Labs to jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats. The collaboration marks a strategic step towards expanding the delivery formats of clinically validated nutraceutical ingredients for global consumers.

The partnership will focus on transforming Zeus Hygia’s proprietary branded ingredients into transdermal delivery systems (TDDS), enabling improved bioavailability, convenience, and compliance. Initial ingredients planned for development include Metaberine®, a clinically validated low-dose berberine for metabolic health and glucose management; STADICE®, an enriched mango extract for cognitive wellness, focus, and memory; and Grantria®, a pomegranate extract positioned for beauty-from-within and menopausal health applications.

Transdermal delivery systems offer several advantages over conventional oral supplementation, including bypassing first-pass metabolism, avoiding degradation in the gastrointestinal tract, and providing sustained, controlled release of active compounds. These attributes make TDDS a promising next-generation delivery platform for nutraceutical and wellness applications.

By combining Zeus Hygia’s proprietary ingredient science with Patch House Labs’ expertise in high-performance topical patch technologies, the partnership aims to accelerate the adoption of transdermal nutraceuticals across Europe and other global markets.

“We see strong synergies between our science-led ingredient platforms and Patch House Labs’ delivery expertise,” said Dr. Arunkanth Krishnakumar, Co-founder and CEO, Zeus Hygia Lifesciences. “This collaboration allows us to extend the reach and efficacy of our clinically validated ingredients through novel delivery formats that enhance consumer experience and therapeutic potential.”

Mr. Isaac Davidson, Founder, Patch House Labs, added, “Zeus Hygia’s commitment to research-driven, premium nutraceutical ingredients aligns strongly with our mission to deliver high-performance transdermal solutions. By combining our formulation and testing capabilities with Zeus Hygia’s patented ingredients, we aim to create differentiated transdermal supplements that can penetrate global markets.”

The MOU reflects the growing convergence of ingredient science and advanced delivery technologies in the nutraceutical industry. As consumer demand for convenient, effective, and science-backed wellness solutions increases, transdermal formats are emerging as a compelling alternative to traditional oral supplements.

The collaboration underscores Zeus Hygia’s ambition to expand its branded ingredient portfolio into next-generation delivery platforms and reinforces Patch House Labs’ position in the premium topical supplement segment.